Authors
Latest:
A United Front for Better Pediatric Clinical TrialsForming strategic alliances and collaborating to optimize study design can significantly improve pediatric drug development.
Latest:
A United Front for Better Pediatric Clinical TrialsForming strategic alliances and collaborating to optimize study design can significantly improve pediatric drug development.
Latest:
3 Key Steps for Building a Successful Research Billing Compliance ProcessBuilding an accurate and consistent billing compliance process is a complex task.
Latest:
Improved Understanding of Psoriasis Buoys Treatment Hopes for PatientsAdvances in our understanding of the genetic, immunological, and environmental factors that contribute to the pathogenesis of psoriasis have led to the development of very effective precision therapies that alleviate patient morbidity and improve quality of life, especially for patients with moderate to severe disease.
Latest:
A Look at Sample and Laboratory Data Management TechnologiesWhat technologies ease clinical trial laboratory sample and data management, and what are the benefits?
Latest:
A Look at Sample and Laboratory Data Management TechnologiesWhat technologies ease clinical trial laboratory sample and data management, and what are the benefits?
Latest:
A Look at Sample and Laboratory Data Management TechnologiesWhat technologies ease clinical trial laboratory sample and data management, and what are the benefits?
Latest:
Developing a Logical Sourcing StrategyThe four essential steps to ensuring optimal clinical deliverable specifications and process controls.
Latest:
Outside-In: Why Putting Patients at the Heart of Drug Development MattersThis article delves into the why, when, and how a patient-centric approach should be adopted for both the benefit of patients and the successful development of novel and innovative medicines.
Latest:
Outside-In: Why Putting Patients at the Heart of Drug Development MattersThis article delves into the why, when, and how a patient-centric approach should be adopted for both the benefit of patients and the successful development of novel and innovative medicines.
Latest:
Trends in Global Public and Patient Perceptions of Clinical ResearchTo inform our understanding of public and patient trust and confidence, this article provides a high-level summary of the results of two studies monitoring trends in international public and patient attitudes and perceptions.
Latest:
Signal Management in Excel is Stifling Pharmacovigilance InnovationDo users actually want to use Excel? Explore the different viewpoints behind choosing SaaS or Excel.
Latest:
Back to Basics? Physician Awareness and Nucleic Acid-Based TherapiesSurvey data finds that physicians aren’t very familiar with the intricacies of nucleic acid-based therapies.
Latest:
User Experience (UX) to Help Participants Find Trials on the WebHealthcare professionals are engaged in an increasingly competitive fight to attract and retain clinical trial participants through the use of user experience (UX).
Latest:
The Transformation of Clinical Trials from Writing on Papyrus to the World of TechnologyNew requirements must be put in place to ensure data quality and integrity.
Latest:
Closer Pharma-Diagnostic Collaboration is Key to Alzheimer’s Drug R&DPharma and diagnostics companies need to strengthen alignment in Alzheimer’s disease research-to help turn science and data into actionable medical innovations.
Latest:
Cancer Trials: Raising Accrual RatesLessons learned from the recruitment of colorectal cander patients into clinical trials.
Latest:
Risk-Based Monitoring Versus Source Data VerificationPilot study compares a risk-based monitoring and remote trial management method with traditional on-site source data verification for trial oversight.
Latest:
Risk-Based Monitoring Versus Source Data VerificationPilot study compares a risk-based monitoring and remote trial management method with traditional on-site source data verification for trial oversight.
Latest:
De-Risking Trials with Science-Driven OversightIdentifying the ‘significant six’ areas of clinical study conduct to mitigate risk.
Latest:
Risk-Based Monitoring Versus Source Data VerificationPilot study compares a risk-based monitoring and remote trial management method with traditional on-site source data verification for trial oversight.
Latest:
Risk-Based Monitoring Versus Source Data VerificationPilot study compares a risk-based monitoring and remote trial management method with traditional on-site source data verification for trial oversight.
Latest:
Risk-Based Monitoring: Barriers to AdoptionExamining the barriers, challenges, and outcomes to determine the effectiveness of different RBM implementation approaches.
Latest:
Risk-Based Monitoring Versus Source Data VerificationPilot study compares a risk-based monitoring and remote trial management method with traditional on-site source data verification for trial oversight.
Latest:
Cold Chain as a ServiceAccording to the IQVIA Institute for Human Data Science, the pharmaceutical industry loses roughly $35 billion annually as a result of temperature excursions, making transport one of the weakest links in many manufacturers’ supply chains.
Latest:
Multiple Expansion Cohort Clinical Trials: A Shorter Path to Success for Oncology DrugsThe rapid rise of targeted drugs and biologics in oncology has spurred sponsors and the FDA to innovate, leading to the creation of a variation to the typical trial design that can include multiple expansion cohorts.
Latest:
Want to Ensure Trial Success? Effective Management of Internal Team Calls may be a KeyIt is important to devote quality time to challenge yourself and your teams on whether there is a need to strategize and rethink the way you are conducting teleconferences for your clinical trials.
Latest:
The Ghost of Clinical Trials Past, Present, and FutureHave you seen many paradigm shifts lately?
Latest:
Data Dilemmas in Clinical Trials ContinueSurvey uncovers key findings amid today’s explosion of data volume and sources-and the added complexity in managing clinical data.
